-+ 0.00%
-+ 0.00%
-+ 0.00%

VOYAGER RECEIVES FDA IND CLEARANCE FOR VY1706, FIRST GENE THERAPY APPROACH TO REDUCING TAU PRODUCTION IN THE BRAIN FOR ALZHEIMER’S DISEASE

Reuters·06/01/2026 12:00:02

Please log in to view news